Bavituximab, referred to as TRWH-783, represents a unique immunotherapy approach targeting phosphatidylserine (PS). PS is normally an cellular lipid found inside cell membranes; however, it's frequently displayed on https://opensocialfactory.com/story25636489/bavituximab-a-novel-approach-to-malignant-therapy